E-Cigarette or Vaping Use-Associated Lung Injury (EVALI)

Key Points

• EVALI is a serious vaping-related lung injury pattern that can progress rapidly to respiratory failure.
• Vaping aerosols may contain nicotine, THC oils, heavy metals, and volatile compounds that worsen oxidative and inflammatory injury.
• Symptoms can overlap with infection and other pulmonary disease, so diagnosis is typically one of exclusion.
• Severe complications include ARDS, pneumothorax, pleural effusion, and diffuse alveolar hemorrhage.
• Nursing priorities are oxygenation support, trend-based reassessment, rapid escalation for deterioration, and cessation counseling.

Pathophysiology

EVALI is associated with inhalation of aerosolized compounds from e-cigarette devices. The heated solution can include nicotine, tetrahydrocannabinol (THC), butane hash oils, cannabidiol, and other additives.

During heating and vaporization, ultrafine particles, volatile compounds, and heavy metals can be delivered to the lower respiratory tract. Some additives can degrade into toxic compounds such as formaldehyde, increasing oxidative stress and inflammatory injury.

This injury pattern can produce hypoxemia, diffuse inflammatory change, and rapid respiratory decline, especially when diagnosis and supportive treatment are delayed.

Classification

• Clinical-severity pattern: Mild hypoxemia with stable work of breathing, moderate oxygen-requiring disease, or severe disease with respiratory-failure trajectory.
• Complication pattern: ARDS, pleural effusion, pneumothorax, hemorrhage, and secondary infection concerns.
• Diagnostic-certainty pattern: Suspected EVALI while excluding competing infectious and structural causes.

Nursing Assessment

NCLEX Focus

Prioritize hypoxemia and respiratory-distress cues before lower-acuity counseling tasks.

• Assess vaping exposure history in detail: products, frequency, nicotine versus THC content, and recent pattern change.
• Assess chest pain, cough, dyspnea, fever, fatigue, headache, myalgia, and bloody sputum.
• Trend respiratory rate, oxygen saturation, and overall work of breathing.
• Monitor for rapid deterioration cues including escalating oxygen need, persistent hypoxemia, and altered mentation.
• Anticipate exclusion-oriented diagnostics: chest x-ray, CT, bronchoscopy, and respiratory viral screening.
• Screen for complications such as pneumothorax, pleural effusion, and ARDS when symptoms worsen despite initial support.

Nursing Interventions

• Stabilize airway-breathing priorities and apply supplemental oxygen as ordered.
• Prepare for admission-level monitoring when hypoxemia or distress is persistent.
• Coordinate ordered diagnostics and specimen workflows rapidly to narrow differential diagnosis.
• Administer ordered therapies (including antibiotics or corticosteroids when indicated by severity and provider plan).
• Escalate immediately for signs of hemorrhage, refractory hypoxemia, or rapidly increasing respiratory effort.
• Support vaping and nicotine cessation planning, including pharmacotherapy referral and structured follow-up.
• Reinforce that e-cigarettes are not a recommended smoking-cessation strategy.
• Coordinate psychosocial support and counseling resources because relapse risk and stress burden are high during recovery.

Exclusion Diagnosis Delay Risk

EVALI can resemble infection or other pulmonary disorders; delayed escalation can increase risk of severe respiratory complications.

Evaluation

Reassess oxygen requirement, dyspnea burden, lung-sound trend, and vital-sign stability at short intervals during acute care. Evaluate cessation progress by tracking vaping and nicotine-use changes, adherence to prescribed medications, and follow-up attendance.

Outcomes are strongest when respiratory status stabilizes, oxygen needs decline, and the patient transitions to sustained no-vaping behavior with documented support resources.

Pharmacology

Drug Class	Examples	Key Nursing Considerations
Supplemental oxygen	Nasal cannula or higher-level delivery	Titrate to ordered targets and reassess frequently for escalation need.
Systemic corticosteroids	Prednisone or methylprednisolone pathways	Often used in severe inflammatory presentations; monitor response and adverse effects.
Empiric antimicrobials	Broad-spectrum pathways per local protocol	Used when infection cannot yet be excluded; de-escalate with diagnostic clarity.
nicotine-replacement-therapy	Patch or gum pathways when appropriate	Support nicotine cessation during recovery and prevent return to vaping nicotine products.

Clinical Judgment Application

Clinical Scenario

A young adult with daily vaping use presents with chest pain, dyspnea, fever, cough, and oxygen saturation decline.

• Recognize Cues: Acute respiratory compromise with exposure history consistent with vaping-related injury.
• Analyze Cues: Differential includes infection, pneumothorax, and EVALI; exclusion-focused workup is needed.
• Prioritize Hypotheses: Immediate priorities are oxygenation stabilization and early detection of severe complications.
• Generate Solutions: Initiate oxygen support, expedite imaging and screening, and prepare escalation pathway.
• Take Action: Implement ordered acute therapies, monitor closely, and activate specialist collaboration.
• Evaluate Outcomes: Oxygen needs decrease, no new complication develops, and cessation plan is accepted.

Related Concepts

• oxygen-therapy - Escalation framework for hypoxemia management.
• acute-respiratory-distress-syndrome - High-severity inflammatory lung injury overlap.
• pneumothorax - Important acute complication to reassess during deterioration.
• nicotine-use-disorder-drugs - Medication-supported cessation planning after vaping injury.
• behavior-modification-counseling-in-cardiopulmonary-care - Structured counseling and relapse-prevention support.

Self-Check

1. Why is EVALI generally treated as a diagnosis of exclusion?
2. Which deterioration cues should trigger immediate escalation?
3. Why should cessation planning start during acute-care stabilization?